NAGE רווח צפוי Chromadex Corp

Scaling B2B supplies of anti-aging components creates growth potential, bolstered by the development of unique nutraceuticals and a strong scientific foundation in longevity. Extrapolation of future profits confirms these expectations, where the current level equals 0.00. Meanwhile, Chromadex Corp strictly adheres to ESG standards, minimizing plastic and optimizing water consumption in the production of dietary supplements.
פילוחים אנליטיים של חברת niagenbioscience.com (NAGE)

For an investor in Chromadex Corp (NAGE), the fundamental value of the asset is determined by the business's ability to generate cash flows over the long term. Analyzing the company's earnings expectations, you see the discounted value of future income through the lens of the cost of capital, which, combined with stable licensing payments and bio-asset sales, confirms the resilience of working capital and the absence of critical cash gaps.